TAYLOR SANDERS: Open Payments
NPI 1952875908 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$739 in 34 payments from 13 companies in 2025. Trend: 2023 $1,621 · 2024 $899 · 2025 $739
Food & beverage: $739
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 15 | $173 |
| Xeris Pharmaceuticals, Inc. | 1 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $122 |
| Collegium Pharmaceutical, Inc. | 4 | $61 |
| Tonix Medicines, Inc. | 2 | $46 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $42 |
| Saluda Medical Americas, Inc. | 2 | $37 |
| Valinor Pharma, LLC | 2 | $31 |
| Globus Medical, Inc. | 1 | $30 |
| Stryker Corporation | 1 | $21 |
Products named: RELISTOR, GVOKE HYPOPEN, Belbuca, TONMYA, JOURNAVX, Evoke, MOVANTIK, Senza.
Industry payments across OK — which companies pay providers there.
